SLC26A9 stimulates CFTR expression and function in human bronchial cell lines

Area of Science:

• Cellular and Molecular Biology
• Ion Channel Physiology
• Respiratory Disease Research

Background:

• Cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial airway anion channel.
• Dysfunctional CFTR underlies cystic fibrosis, a genetic disorder.
• Understanding CFTR interactions is key to developing new therapies.

Purpose of the Study:

• To investigate functional and physical interactions between SLC26A9 and CFTR.
• To determine if SLC26A9 modulates CFTR activity, particularly the ΔF508 mutant.
• To explore the mechanism behind SLC26A9's effect on CFTR.

Main Methods:

• Utilized bronchial epithelial cell lines (CFBE41o-) expressing wild-type (WT) or ΔF508 CFTR.
• Employed lentiviral transduction to express SLC26A9.
• Performed immunoblots, co-immunoprecipitation, and electrophysiological recordings (two-electrode voltage clamp in Xenopus oocytes).

Main Results:

• SLC26A9 expression increased CFTR protein levels in both WT and ΔF508 cell lines.
• SLC26A9 enhanced forskolin-stimulated currents in CFTR(WT) expressing cells and Xenopus oocytes, indicating increased CFTR activity.
• No significant enhancement of CFTR activity was observed with SLC26A9 in CFTR(ΔF508) expressing cells or oocytes.
• Co-immunoprecipitation confirmed a physical interaction between SLC26A9 and CFTR.

Conclusions:

• SLC26A9 physically interacts with CFTR.
• SLC26A9 stimulates the activity of wild-type CFTR but not the ΔF508 mutant.
• This stimulation is likely due to SLC26A9 promoting CFTR biogenesis and/or stability.